DOLSTEN MIKAEL reported 2 transactions at APELLIS PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 5/14/2026ACC: 0001193125-26-224624
Director
Since Mar 2026
-52.76K
Net shares
Net seller
$0.00
Total acquired
0
Open market trades
0B · 0S
3
Total transactions
52.76K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
−14.31K
Price / share
—
Trade value
—
% of position
New position
5/14/2026
14.31K→0.00
Common Stock
Direct
Shares
−14.31K
Price / share
—
Trade value
—
% of position
New position
5/14/2026
14.31K→0.00
Total
Net shares
−28.62K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 5/14/2026 | U · U | −14.31K | — | — | New position | 14.31K | 0.00 |
| Common Stock Direct | 5/14/2026 | D · Disposition | −14.31K | — | — | New position | 14.31K | 0.00 |
| Total | −28.62K | $0.00 | ||||||
Derivative Transactions1
Stock Option (right to buy)
Direct
Converts to
Common Stock
24.14K shares
Shares
−24.14K
Strike price
20.96
Held after
0.00
Exercisable
—
5/14/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Stock Option (right to buy) Direct | Common Stock24.14K shares | 5/14/2026 | D · Disposition | −24.14K | 20.96 | — | 0.00 |